Evidence map›Paper›PMID 22496656›Full record

ArticlePLoS pathogens2012

Leishmania induces survival, proliferation and elevated cellular dNTP levels in human monocytes promoting acceleration of HIV co-infection.

David J Mock, Joseph A Hollenbaugh, Waaqo Daddacha, Michael G Overstreet, Chris A Lazarski, Deborah J Fowell, Baek Kim

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
5.0field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 63 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Review
  4. Review
  5. Article
  6. Article
  7. An Update on Clinical and Pathogenic Spectra of Leishmaniasis.Expert reviews in molecular medicine · 2025
    Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. DNA methylation alterations caused byFrontiers in cellular and infection microbiology · 2022
    Review
  16. Article
  17. Visceral Leishmaniasis-HIV Coinfection as a Predictor of IncreasedFrontiers in cellular and infection microbiology · 2021
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

David J MockDepartment of Biomolecular Genetics, University of Rochester Medical Center, Rochester, New York, United States of America. david_mock@urmc.rochester.edu
Joseph A Hollenbaugh
Waaqo Daddacha
Michael G Overstreet
Chris A Lazarski
Deborah J Fowell
Baek Kim
University of Rochester Medical Center · USGenVec · US

Funding

Replication fidelity and lentiviral pathogenesisR01AI049781 · NIAID · UNIVERSITY OF ROCHESTER · PI KIM, BAEK · 2002 to 2016
$4.9M
Remodeling of Lymph Node-Derived Cytokine Responses at the Infected Tissue SiteR01AI072690 · NIAID · UNIVERSITY OF ROCHESTER · PI FOWELL, DEBORAH J · 2008 to 2020
$3.6M
PHARMACOLOGY OF DRUG ABUSET32DA007232 · NIDA · UNIVERSITY OF ROCHESTER · PI BIDLACK, JEAN M · 1985 to 2011
$2.1M
Targeting PI3K/Akt Cell Survival Pathway as a Novel Anti-HIV TherapyR01AI077401 · NIAID · UNIVERSITY OF ROCHESTER · PI KIM, BAEK · 2009 to 2012
$1.4M
Mechanistic Interplays between cPP Tract and RT Inhibitor Sensitivity of HIV-1F31GM095190 · NIGMS · UNIVERSITY OF ROCHESTER · PI DADDACHA, WAAQO BORU · 2011 to 2013
$109k
Defining modes of helper T cell motility within inflamed tissuesF32AI089079 · NIAID · UNIVERSITY OF ROCHESTER · PI OVERSTREET, MICHAEL GLEN · 2011 to 2012
$76k
NIAID NIH HHS AI077401NIAID NIH HHS F32 AI089079NIAID NIH HHS F32 AI089079-01A1NIAID NIH HHS R01 AI049781NIAID NIH HHS R01 AI072690NIDA NIH HHS T32 DA007232NIDA NIH HHS T32 DA07232NIGMS NIH HHS F31 GM095190
6 · The paper itself

Abstract

Leishmaniasis is a parasitic disease that is widely prevalent in many tropical and sub-tropical regions of the world. Infection with Leishmania has been recognized to induce a striking acceleration of Human Immunodeficiency Virus Type 1 (HIV-1) infection in coinfected individuals through as yet incompletely understood mechanisms. Cells of the monocyte/macrophage lineage are the predominant cell types coinfected by both pathogens. Monocytes and macrophages contain extremely low levels of deoxynucleoside triphosphates (dNTPs) due to their lack of cell cycling and S phase, where dNTP biosynthesis is specifically activated. Lentiviruses, such as HIV-1, are unique among retroviruses in their ability to replicate in these non-dividing cells due, at least in part, to their highly efficient reverse transcriptase (RT). Nonetheless, viral replication progresses more efficiently in the setting of higher intracellular dNTP concentrations related to enhanced enzyme kinetics of the viral RT. In the present study, in vitro infection of CD14+ peripheral blood-derived human monocytes with Leishmania major was found to induce differentiation, marked elevation of cellular p53R2 ribonucleotide reductase subunit and R2 subunit expression. The R2 subunit is restricted to the S phase of the cell cycle. Our dNTP assay demonstrated significant elevation of intracellular monocyte-derived macrophages (MDMs) dNTP concentrations in Leishmania-infected cell populations as compared to control cells. Infection of Leishmania-maturated MDMs with a pseudotyped GFP expressing HIV-1 resulted in increased numbers of GFP+ cells in the Leishmania-maturated MDMs as compared to control cells. Interestingly, a sub-population of Leishmania-maturated MDMs was found to have re-entered the cell cycle, as demonstrated by BrdU labeling. In conclusion, Leishmania infection of primary human monocytes promotes the induction of an S phase environment and elevated dNTP levels with notable elevation of HIV-1 expression in the setting of coinfection.

Indexed as

HIV InfectionsLeishmaniasis, CutaneousMacrophagesCell Cycle ProteinsDeoxyribonucleotidesFemaleGene Expression Regulation, EnzymologicGene Expression Regulation, ViralHIV-1HIV Reverse TranscriptaseHumansLeishmania majorMaleMonocytesRibonucleotide ReductasesS PhaseCell Cycle ProteinsDeoxyribonucleotidesHIV Reverse TranscriptaseRibonucleotide ReductasesRRM2B protein, human

Identifiers

PMID22496656
PMCPMC3320607
OpenAlexW2080671996

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.